Calling for benefit-risk evaluations of COVID-19 control measures

Lancet. 2021 Feb 13;397(10274):576-577. doi: 10.1016/S0140-6736(21)00193-8. Epub 2021 Feb 4.

Authors

Günter Kampf¹, Martin Kulldorff²

Affiliations

¹ Institute for Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald 17475, Germany. Electronic address: guenter.kampf@uni-greifswald.de.
² Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Harvard Medical School, Boston, MA, USA.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / prevention & control*
COVID-19 / psychology
Depression / epidemiology
Emergency Service, Hospital / statistics & numerical data
Facilities and Services Utilization
Health Policy
Humans
Pandemics / prevention & control
Physical Distancing
Prevalence
Risk Assessment*
SARS-CoV-2
Social Support